Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Raptech who wrote (1327)	8/3/1998 10:52:00 PM
From: Steve Harmon	Respond to of 2742

Very heavy accumulation on Friday....the manipulators continue to play their VERY dangerous game of Russian Roulette with Cistron at these levels!

To: Raptech who wrote (1327)	8/4/1998 12:07:00 AM
From: scaram(o)uche	Respond to of 2742

Rap: You can't come to that conclusion without a bit of perspective, perspective that Galton et al. didn't provide. If it is for non-gene-based delivery and is restricted to selected indications, it's not a bad deal at all (IMO). IL-1beta can be licensed for several indications and in different forms. This could be, if Galton can pull it off, the first of several deals. Rick